Bezisterim (NE3107)

MedicationExperimental0 reviews

—

Average score out of 5

Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.

Bezisterim (NE3107) is an investigational drug that inhibits ERK/NF-κB-mediated inflammation. It is being studied for its potential to reduce neuroinflammation and cognitive symptoms (brain fog) in Long COVID.

Information

Subcategory: inflammation modulator
Evidence level: 2/5
Evidence type: randomized controlled trial (phase 2)

Share your experience

Your feedback helps thousands of people find what really works.

Join the community